On Friday, Oklahoma Attorney General said that he made an out-of-court settlement of $8.75 million with Endo Pharmaceuticals over the opioids crisis.
The settlement amount will be added to a fund set up from the previously obtained $85 million settlement with Teva Pharmaceuticals last year. Also, Endo will neither employ sales representatives to promote opioids in the state, nor support information promoting opioids as a part of the settlement. The Attorney General said that money from this settlement, as well as the money from other settlements, will be used to abate Oklahoma’s opioid epidemic. According to estimation, as many as 100,000 Oklahomans are struggling with opioid addiction, and every 25 minutes, a baby is born suffering from opioid withdrawal as per the attorney general.
Purdue Pharma also made a $270 million settlement last year with the state, following which the company filed for Chapter 11 bankruptcy protection.
Meanwhile, the Michigan Department of Health and Human Services (MDHHS) has announced the allocation of $17.5 million from the State Opioid Response (SOR) Grant over the opioid epidemic. The amount will be used for support services for individuals at the highest risk of overdose, including offering medications to treat opioid use disorder, as well as naloxone within the criminal justice system and in the emergency department following an overdose.
